Type 1 Immunity Provides Optimal Protection against Both Mucosal and Systemic Trypanosoma cruzi Challenges
Chagas' disease results from infection with Trypanosoma cruzi, a protozoan parasite that establishes systemic intracellular infection after mucosal invasion. We hypothesized that ideal vaccines for mucosally invasive, intracellular pathogens like T. cruzi should induce mucosal type 2 immunity for op...
保存先:
| 出版年: | Infect Immun |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC132946/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12438346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.12.6715-6725.2002 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|